Placulumab

DB11983InvestigationalProtein Based Therapies

Placulumab has been used in trials studying the treatment of Rheumatoid Arthritis.

Mechanism: Pharmacologically active on Tumor necrosis factor
Curator reviewed
Code names: ART621

Resolves to

Compound

Targets

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

3Clinical trialsPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with Placulumab, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.